SPRY insider trading
NasdaqGM HealthcareARS Pharmaceuticals, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About ARS Pharmaceuticals, Inc.
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally. The company is involved in the development of neffy, a needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.
Company website: ars-pharma.com
SPRY insider activity at a glance
FilingIQ has scored 341 insider transactions for SPRY since Nov 8, 2022. The most recent filing in our index is dated Jan 2, 2026.
Across the full history, 11 open-market purchases
and 221 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on SPRY insider trades is 66.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest SPRY Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for SPRY?
- FilingIQ tracks 341 Form 4 insider transactions for SPRY (ARS Pharmaceuticals, Inc.), covering filings from Nov 8, 2022 onwards. 0 of those were filed in the last 90 days.
- Are SPRY insiders net buyers or net sellers?
- Across the full Form 4 history for SPRY, 11 transactions (3%) were open-market purchases and 221 (65%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does SPRY insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is SPRY in?
- ARS Pharmaceuticals, Inc. (SPRY) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $784.45M.
Methodology & sources
Every SPRY insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.